A senior manager in the Health Service Executive sold a privately owned apartment to the Peter McVerry Trust shortly after he signed off on funding for the housing charity.
RTÉ Investigates attempted to contact Mr Cassidy repeatedly. Among several questions asked was whether he had disclosed the apartment sale to HSE management, and whether it posed a potential conflict of interest. Mr Cassidy did not respond.The Peter McVerry Trust also declined to answer any questions relating to the transaction.
Separately, ethics legislation requires HSE employees above a certain salary grade to complete an annual written statement of interest if they have a potential conflict of interest. The HSE explained that those employees must set out in writing"interests… which could materially influence" them in performing their official duties.
"The Service Arrangement sets out the funding provided and the specific level of service that is agreed to be provided for the funding. Service Arrangements are approved in line with HSE National Financial Regulations."On several occasions, HSE funding-related documentation for 2020 and 2021 involving the Peter McVerry Trust references Mr Cassidy. The 2020 service arrangement, signed on 28 February 2020, described Mr Cassidy as the"Service Lead" on a list of key contacts.
Mr Cassidy signed the document on behalf of the HSE. In this instance, he was referred to as the"Acting Head of Service Primary Care, HSE CHO DNCC." According to the Property Price Register, the Swords apartment was sold on 9 April 2020. In May 2022, as part of a project on conflicts of interest in the public healthcare system, RTÉ Investigates submitted a freedom of information request to the HSE seeking copies of registers used to record the receipt of statements of interest by its staff.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimes - 🏆 3. / 98 Read more »
Source: IrishMirror - 🏆 4. / 98 Read more »
Source: IrishTimes - 🏆 3. / 98 Read more »
'Significant milestone': HSE approves breast cancer drugThe approval by the HSE of a new treatment option for people with breast cancer at high-risk of recurrence, which could reduce the chance of their cancer returning by 30%, has been welcomed as a 'significant milestone'.
Source: rtenews - 🏆 1. / 99 Read more »